Home

Not a member? Sign up!

Forgot your password?

Merck fails to disclose mortality risk associated with Vioxx

Added: July 15, 2008 | Time 02:20 | Views: 245

Litigation involving drug maker Merck has revealed new information about safety concerns associated with the drug Vioxx, pulled from the market in 2004. Legal documents recently made public show the company found an increased risk in mortality rates during clinical trials to treat patients with Alzheimer’s disease but the dangers were never made clear to the public.

Topics: Alzheimer's Disease

Tags: Alzheimer’s disease, jama report, Merck, Vioxx

Embed:

Comments

Post a Comment

Please log in at the top of the page to post a comment!

Popular Health Topics

Community

Company Information

Site Links

Resources / Support

By using this service, you accept our Terms of Service. Please read them. The health information on this site is for informational purposes only and is not a substitute for medical advice or treatment for any medical conditions. You should promptly seek professional medical care if you have any concern about your health, and you should always consult your physician before starting a fitness regimen.